Main > ENDOCRINOLOGY > Diabetes. Treatment > Meglitinide Class Drugs > NateGlinide. > NonGeneric Nateglinide > Patent. > Claims > Claim 1: Compn Nateglinide (0.1-35% > ); Sugar(24-46%); & > MicroCrystalline Cellulose(17-23%) > Claim 2: Sugar: Lactose. Claim 4: > Tablet Form. Claim 5: > Gelatin Capsule. Claim 6: Granular > Compn. Claim 7: Liquid. Claim 8: > Suspension. Claim 9: Diabetes > Treat Compn. Patent Assignee
Treat Compn. Patent Assignee's products
CH. N
CH. N